Novel Umbilical Cord Blood-Derived Multi-Chimeric Cell (MCC) Therapy for Tolerance Induction in Bone Marrow, Solid Organs, and Vca Transplantation
Main Authors: | Maria Siemionow, MD, PhD, DSc, Lucile Chambily, MD, Joanna Cwykiel, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2024-01-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0001005848.15561.37 |
Similar Items
-
Efficacy of Engraftment and Safety of Human Umbilical Di-Chimeric Cell (HUDC) Therapy after Systemic Intraosseous Administration in an Experimental Model
by: Maria Siemionow, et al.
Published: (2024-05-01) -
Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration
by: Katarzyna Budzynska, et al.
Published: (2024-05-01) -
Abstract 51: Tolerance Induction Protocol For VCA Across Full Mismatch Barriers In MHC-Defined Miniature Swine
by: Alec R. Andrews, BS, et al.
Published: (2020-04-01) -
103. Extended VCA Preservation Using Supercooling In A Pig Model
by: Yanis Berkane, MD, MSc, et al.
Published: (2024-04-01) -
Delayed type hypersensitivity injection site reaction and tolerance induction to liraglutide for the treatment of obesity
by: Martina Yaneva, MD, et al.
Published: (2023-08-01)